Suppr超能文献

在加拿大蒙特利尔的一家艾滋病三级护理诊所中,气流阻塞的流行情况和预测因素:一项横断面研究。

Prevalence and predictors of airflow obstruction in an HIV tertiary care clinic in Montreal, Canada: a cross-sectional study.

机构信息

Chronic Viral Illness Service/Division of Infectious Diseases, Research Institute of the McGill University Health Centre, Montreal, QC, Canada.

Department of Medicine, National University of Ireland, Galway, Ireland.

出版信息

HIV Med. 2019 Mar;20(3):192-201. doi: 10.1111/hiv.12699. Epub 2019 Jan 8.

Abstract

OBJECTIVES

The reported prevalence of chronic obstructive pulmonary disease (COPD) in people living with HIV (PLWHIV) varies widely. Our objective was to estimate the prevalence of airflow obstruction and COPD in unselected PLWHIV and identify characteristics that increase the risk of nonreversible airflow obstruction in order to guide case finding strategies for COPD.

METHODS

All adults attending the Chronic Viral Illness Service were invited to participate in the study, regardless of smoking status or history of known COPD/asthma. Individuals underwent spirometric testing both before and after use of a salbutamol bronchodilator. Airflow obstruction was defined as forced expiratory volume in 1 s (FEV )/forced vital capacity (FVC) < 0.7 post-bronchodilation, whereas COPD was defined as FEV /FVC < 0.7 post-bronchodilation and Medical Research Council (MRC) score > 2. Multivariate logistic regression was used to evaluate risk factors associated with airflow obstruction, reported as adjusted odds ratios (aORs).

RESULTS

Five hundred and three participants successfully completed spirometry testing. The median (Q1; Q3) age was 52 (44; 58) years. The median (Q1; Q3) CD4 count was 598 (438; 784) cells/μL and the median (Q1; Q3) nadir CD4 count was 224 (121; 351) cells/μL. There were 119 (24%) current smokers and 145 (29%) former smokers. Among those screened, 54 (11%) had airflow obstruction whereas three (1%) of the participants had COPD. Factors that were associated with airflow obstruction included a history of smoking [aOR 2.2; 95% confidence interval (CI) 1.1; 4.7], older age (aOR 1.6; 95% CI 1.2; 2.2), and lower CD4 count (aOR 0.8; 95% CI 0.7; 1.0).

CONCLUSIONS

Airflow obstruction was relatively uncommon. Our findings suggest that PLWHIV who are ≥50 years old, smokers and those with nadir CD4 counts ≤ 200 cells/μL could be targeted to undergo spirometry to diagnose chronic airflow obstruction.

摘要

目的

患有人类免疫缺陷病毒(HIV)的人群中慢性阻塞性肺疾病(COPD)的报告患病率差异很大。我们的目的是估计未经选择的 HIV 感染者中气流阻塞和 COPD 的患病率,并确定增加不可逆气流阻塞风险的特征,以便为 COPD 病例发现策略提供指导。

方法

无论吸烟状况或已知 COPD/哮喘病史如何,所有参加慢性病毒感染服务的成年人都被邀请参加研究。个体在使用沙丁胺醇支气管扩张剂前后均接受了肺量计测试。气流阻塞定义为支气管扩张后 1 秒用力呼气量(FEV )/用力肺活量(FVC)<0.7,而 COPD 定义为支气管扩张后 FEV /FVC<0.7 和医学研究委员会(MRC)评分>2。使用多变量逻辑回归评估与气流阻塞相关的危险因素,报告为调整后的优势比(aOR)。

结果

503 名参与者成功完成了肺量计测试。中位(Q1;Q3)年龄为 52(44;58)岁。中位(Q1;Q3)CD4 计数为 598(438;784)细胞/μL,中位(Q1;Q3)最低 CD4 计数为 224(121;351)细胞/μL。有 119 名(24%)现吸烟者和 145 名(29%)前吸烟者。在接受筛查的人群中,有 54 名(11%)患有气流阻塞,有 3 名(1%)参与者患有 COPD。与气流阻塞相关的因素包括吸烟史[aOR 2.2;95%置信区间(CI)1.1;4.7]、年龄较大[aOR 1.6;95%CI 1.2;2.2]和较低的 CD4 计数[aOR 0.8;95%CI 0.7;1.0]。

结论

气流阻塞相对少见。我们的研究结果表明,年龄≥50 岁、吸烟者和最低 CD4 计数≤200 细胞/μL 的 HIV 感染者可能是进行肺量计检查以诊断慢性气流阻塞的目标人群。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b749/6590155/dd499616d716/HIV-20-192-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验